bims-mascan Biomed News
on Mass spectrometry in cancer research
Issue of 2025–10–12
27 papers selected by
Giovanny Rodríguez Blanco, Uniklinikum Graz



  1. Anal Chem. 2025 Oct 06.
      Isobaric labeling techniques are widely used in mass spectrometry-based quantitative proteomics to enable the simultaneous analysis of multiple samples. However, commercial isobaric tags are expensive due to complex synthesis and costly reagents, limiting their use in large-scale studies. Here, we introduce a novel, cost-effective diethylalanine-based isobaric reagent (DeAla), synthesized using diethylated alanine and β-alanine with N-hydroxysuccinimide. The DeAla tag offers several advantages, including improved peptide fragmentation, enhanced protein identification, and competitive pricing. We optimized labeling efficiency and collision energy parameters, demonstrating that DeAla-labeled peptides produce more backbone fragmentation ions and higher XCorr values compared to peptides labeled with N,N-dimethyl leucine (DiLeu) tags. By selectively incorporating stable isotopes, we expanded the multiplexing capacity to 13-plex without increasing structural complexity, achieving baseline resolution in Orbitrap MS/MS acquisition at 60k resolution. Comparative proteomic analyses of two cancer cell lines demonstrated that DeAla labeling outperformed DiLeu tags and showed comparable performance to label-free approaches in terms of protein and peptide identification. Additionally, DeAla provided accurate and reproducible quantification across a dynamic range with minimal technical variability. Overall, the 13-plex DeAla reagents are cost-effective, high-performance isobaric tagging tools that enhance peptide fragmentation and protein identification while ensuring high quantification accuracy, making them valuable for complex quantitative proteomic analyses.
    DOI:  https://doi.org/10.1021/acs.analchem.5c03910
  2. Anal Chem. 2025 Oct 07.
      Untargeted metabolic profiling of plasma and serum by liquid chromatography-mass spectrometry (LC-MS) is becoming increasingly important in clinical and translational research; however, sample preparation protocols can have a significant impact on study outcomes, and there is currently a lack of standardized approaches. In this study we demonstrate that pretreatment of serum and plasma samples with 1% formic acid (FA, v/v) prior to acetonitrile (MeCN)-induced protein precipitation significantly enhances analytical performance in untargeted metabolomics using reversed-phase liquid chromatography (RPLC)-MS. We show an increase in sample preparation reproducibility and signal intensity across both positive and negative ionization modes. In two independent serum cohorts (OPTIMA and VITACOG), FA-based extraction improved multivariate modeling (orthogonal partial least-squares discriminant analysis, OPLS-DA), with consistently higher classification accuracy, sensitivity, and specificity, alongside reduced variability and increased fold-changes in discriminatory compound-features. We investigated factors potentially involved in the enhanced performance and observed outcomes consistent with the disruption of noncovalent protein-metabolite interactions and the stabilization of labile species. We found no correlation with either protein depletion or differential adduct formation. The results were also not attributable to lowering pH after metabolite extraction. In summary, we demonstrate that FA pretreatment of plasma and serum, prior to protein precipitation, significantly improves sample reproducibility and detection sensitivity in untargeted RPLC-MS metabolomics. This optimized sample preparation strategy offers clear advantages for clinical and translational metabolomics, with the potential to enhance biomarker discovery and metabolic phenotyping.
    DOI:  https://doi.org/10.1021/acs.analchem.5c03725
  3. Anal Chim Acta. 2025 Nov 22. pii: S0003-2670(25)01009-8. [Epub ahead of print]1376 344615
       BACKGROUND: Untargeted drug-metabolite identification continues to be challenged by the tradeoff between comprehensive coverage and acceptable false-positive rates. Our previously developed two-dose-difference platform combined with stable isotope tracing (SIT) achieved highly comprehensive and accurate metabolite detection. However, this approach still produced a large false-positive rate. Thus, it is critical to develop strategies that reduce the false-positive burden.
    RESULTS: We benchmarked four data-processing workflows-original two-dose-difference + SIT, modified two-dose-difference + SIT (with a mass shift defect filter), dose-response + SIT, and mass defect filtering + SIT-using nifedipine (NIF) as a probe. UPLC-MS data were acquired under three incubation setups: coincubation of NIF with isotope-labeled analog (D4-NIF), separate incubations, and postreaction mixing of supernatants. Targeted MS/MS validation confirmed 65 putative NIF metabolites, including three previously reported. Among the four data-processing workflows, the original and modified two-dose-difference + SIT workflows proved to be the most comprehensive for NIF metabolite identification. Compared with the original two-dose-difference + SIT workflow, the modified workflow identified all putative NIF metabolites and improved the true-positive rate from 36.9 % to 71.0 % in the coincubation setup. Separate incubation yielded the most comprehensive profile (56 features) compared to coincubation (44) or mixed supernatants (38), indicating coincubation may obscure certain metabolites. Performance of the modified workflow remained consistent irrespective of dosing levels.
    SIGNIFICANCE: By incorporating a mass shift defect filter into the two-dose-difference + SIT workflow, we more than doubled the true-positive discovery rate-from 36.9 % to 71.0 %-without sacrificing metabolite coverage. This streamlined, dose-independent method reduces false positives and accelerates reliable metabolite identification, offering a practical, resource-efficient platform for early-stage drug metabolism studies and mechanistic pharmacology.
    Keywords:  Mass defect filtering; Mass shift defect; Stable isotope filtering; Two-dose difference
    DOI:  https://doi.org/10.1016/j.aca.2025.344615
  4. Anal Bioanal Chem. 2025 Oct 06.
      Chemical derivatization is a powerful strategy for enhancing the chromatographic behavior and mass spectrometric sensitivity of lipids, which play an essential role in cellular processes and show high potential in cancer biomarker research. In this study, we describe a targeted and validated method that combines benzoyl chloride derivatization with reversed-phase ultrahigh-performance liquid chromatography tandem mass spectrometry (RP-UHPLC/MS/MS) for the quantitative analysis of the human serum lipidome. In total, 450 lipid species from 19 lipid subclasses were identified based on a combination of multiple reaction monitoring transitions, retention dependencies, dilution series, and derivatization tags. The developed methodology increases the sensitivity for most investigated lipid classes in comparison to conventional methods, but the highest improvement was observed for monoacylglycerols, diacylglycerols, sphingoid bases, and free sterols. The method's accuracy was confirmed using NIST SRM 1950, as the determined concentrations were in agreement with the consensus values from ring trials. Lipidomic profiling of clinical samples revealed a significant dysregulation of lipid metabolism in pancreatic cancer patients compared to healthy controls. Key findings included the upregulation of most monoacylglycerols and sphingosine, and a pronounced downregulation of sphingolipids with very long saturated N-acyl chains and phospholipids containing fatty acyl compositions 18:2 and 20:4. This targeted approach is consistent with the trends previously seen with other methods and also provides new findings and more detailed structural insights into metabolic alterations in pancreatic cancer.
    Keywords:  Derivatization; Human serum; Lipidomic quantitation; Liquid chromatography; Mass spectrometry; Pancreatic cancer
    DOI:  https://doi.org/10.1007/s00216-025-06151-0
  5. Nat Commun. 2025 Oct 08. 16(1): 8952
      Cancer cells have the unique capability to upregulate the de novo nucleotide biosynthesis supporting cell survival under nucleotide deprivation. We probe the role of metabolic channeling and membrane-less metabolic compartmentalization by mitochondria-proximal dynamic de novo pyrimidine and purine biosynthesis metabolons, the pyrimidinosome and the purinosome, respectively. We designed in-cell stable isotope label incorporation assays (13C6 glucose, 15N2 glutamine) for detection of metabolic channeling, revealing the function and enzymatic composition of these complexes. Moreover, we discovered that the mitochondrially compartmentalized GOT2 dependent generation of aspartic acid feeds the channeled nucleotide synthesis instead of the bulk cytosolic pool or the GOT1 activity. While a low flux diffusive pathway generates the pathway intermediates in an accumulative process, it's the channeled pathway that successfully generates the end product nucleotides. Our results demonstrate how metabolic channeling and efficient de novo nucleotide biosynthesis is fueled by coordination of mitochondrially compartmentalized metabolic events with cytosolic metabolons in cancer cells.
    DOI:  https://doi.org/10.1038/s41467-025-64013-w
  6. Anal Chim Acta. 2025 Nov 22. pii: S0003-2670(25)00850-5. [Epub ahead of print]1376 344456
       BACKGROUND: In recent years, there has been growing interest in the development of advanced lipidomic techniques capable of resolving lipid isomers. The Paternò-Büchi (PB) reaction, coupled with tandem mass spectrometry (MS/MS), has emerged as a powerful tool for analysis of unsaturated lipids.
    RESULTS: This review introduces basic principles of PB-MS/MS for identification and quantitation of CC location isomers of lipids and its utilization in determining sn-position and the geometry of CC. Then, the approaches for integrating PB-MS/MS into lipidomic workflows are discussed, including shotgun analysis, direct analysis, online and offline coupling with liquid chromatography-MS, single-cell analysis, and mass spectrometry imaging. Examples are provided to illustrate how deep profiling enabled by PB-MS/MS offers crucial insights into lipid metabolism at the isomer level and facilitates lipidomic phenotyping of diseased tissues and single cells. Finally, the challenges and future directions for the advancement of PB-MS/MS are discussed.
    SIGNIFICANCE: This review summarizes recent advancements in PB-MS/MS, an important tool for structural lipidomics, with a focus on aiding researchers in selecting an appropriate strategy for their specific applications in both fundamental and translational research.
    Keywords:  Isomers; Lipid derivatization; Lipidomics; Liquid chromotography; Paternò−Büchi reaction; Tandem mass spectrometry
    DOI:  https://doi.org/10.1016/j.aca.2025.344456
  7. Acc Chem Res. 2025 Oct 07.
      ConspectusMass spectrometry imaging (MSI) has transformed our ability to explore molecular distributions in biological tissues with high chemical specificity and sensitivity. Despite significant advances in this field, the absence of separation prior to analysis leads to isomeric and isobaric overlaps, posing a major analytical challenge. To enhance chemical specificity and enable isomer differentiation, tandem mass spectrometry, ion mobility spectrometry, chemical complexation, and derivatization strategies are increasingly integrated into MSI workflows.Ambient ionization MSI techniques provide both chemical and spatial information under native or near-native conditions, enabling rapid, label-free molecular imaging of complex biological samples with minimal sample pretreatment. Among the most promising ambient MSI techniques is nanospray desorption electrospray ionization (nano-DESI), a method that relies on localized liquid extraction directly from biological tissue sections. We have successfully implemented custom-designed nano-DESI platforms on multiple commercial mass spectrometers to enable molecular identification at each pixel of the image and facilitate isomer-selective mass spectrometry imaging (iMSI).This Account highlights recent advances in iMSI using nano-DESI. Key developments include the integration of nano-DESI with multiple reaction monitoring on a triple quadrupole mass spectrometer to differentiate isomeric lipids in biological tissues. We also describe the integration of photoinitiated derivatization and metal ion complexation strategies to enable isomer-selective imaging using structure-specific fragments generated by collision induced dissociation. Furthermore, high-resolution separation of lipid isomers was achieved by coupling nano-DESI with trapped ion mobility spectrometry, demonstrating the value of gas-phase separation for iMSI. These innovations have significantly expanded the analytical capabilities of MSI critical to probing the spatial organization of isomeric lipids and metabolites in biological systems. We also discuss future directions, including new complexation strategies and the integration of nano-DESI with data-independent acquisition and parallel accumulation serial fragmentation technologies. Collectively, these advances establish nano-DESI iMSI as a powerful and versatile tool in the evolving field of spatial metabolomics and lipidomics.
    DOI:  https://doi.org/10.1021/acs.accounts.5c00532
  8. Analyst. 2025 Oct 07.
      Comprehensive metabolomics requires robust and efficient analytical techniques capable of addressing the chemical diversity, complexity, and high sample throughput demands characteristic of large-scale studies. We introduce a rapid, mixed-mode liquid chromatography method that uniquely integrates anion exchange and hydrophobic interactions within a single stationary phase. Employing an optimized ternary gradient, our method achieves comprehensive separation of diverse metabolite classes over a wide range of polarities within only 4 minutes per run. The performance was tested with standards for ca. 1000 metabolites. For two-thirds of 94 isomeric sets, we could achieve a separation of 2 or more seconds, which is sufficient for correct identification. We demonstrate robustness over 500 consecutive injections of bacterial extracts and with the analysis of complex matrices like plasma, cecum extracts, and urine. Throughout, retention time drifts were <1 s. Our mixed-mode LC-MS approach offers a routine throughput of 360 samples per day per instrument and is ideally suited for studies that require rapid and comprehensive metabolic profiling.
    DOI:  https://doi.org/10.1039/d5an00641d
  9. J Vis Exp. 2025 Sep 16.
      Single-cell mass spectrometry (SCMS) has become an indispensable tool for studying cellular metabolism. Owing to advancements in modern mass spectrometry (MS) techniques and demand in studies of cell heterogeneity in fundamental biological sciences and human diseases, a variety of different SCMS techniques have been developed and applied in laboratory research. As metabolites can accurately reflect cell status, SCMS metabolomics analysis of live cells is regarded as a powerful tool to provide molecular information about cells. However, a major challenge in SCMS analysis of live cells is preserving the endogenous metabolite profiles during sample preparation, transport, and measurement. Cellular metabolites undergo rapid turnover and are highly sensitive to environmental changes, making them susceptible to degradation or transformation prior to analysis. To address this limitation, we present a robust and reproducible cell preparation protocol designed to preserve cellular metabolite integrity for SCMS. The protocol integrates cell washing with a volatile ammonium formate (AF) solution, rapid quenching with liquid nitrogen (LN2), vacuum freeze-drying, and storage at -80 °C. This approach minimizes cell membrane damage while effectively halting metabolic activity. The results indicate that rapid cell quenching is vital; however, limiting storage time at -80 °C is necessary to preserve cell metabolites. The proposed protocol can potentially be used for other existing SCMS techniques for broad applications.
    DOI:  https://doi.org/10.3791/68995
  10. Nat Protoc. 2025 Oct 09.
      Filter-aided expansion proteomics (FAXP) is a spatial proteomics approach designed for high-resolution analysis of formalin-fixed, paraffin-embedded (FFPE) tissues. Here we describe the integration of hydrogel-based tissue expansion with mass spectrometry, enabling isotropic expansion and robust protein retention while preserving spatial features. The FAXP workflow consists of several sequential steps, including tissue section dewaxing, in situ protein anchoring, hydrogel embedding, homogenization, staining, isotropic expansion, microdissection and filter-aided in-gel digestion to maximize peptide recovery. The Protocol integrates laser capture microdissection, enabling the precise isolation of single cells and subcellular components for subcellular spatial proteomics analysis. The approach achieves up to a fivefold linear expansion factor of FFPE tissue, including extracellular matrix-rich samples such as colorectal cancer, with less than 6% distortion, enabling the identification of an average of 2,368 proteins from single mouse liver nucleus shape and 3,312 proteins from single mouse liver cell shape using an Astral mass spectrometer. The method is compatible with diverse tissue types, including extracellular matrix-rich specimens, and integrates seamlessly with imaging workflows, such as immunostaining, for spatially resolved proteomic analysis. FAXP enables researchers to obtain comprehensive proteomic profiles with strong reproducibility and high sensitivity. The entire workflow takes ~27 h and requires only commercially available reagents and supplies and is thus accessible for researchers with intermediate expertise in tissue processing, microscopy and proteomics. FAXP can advance spatial proteomics-based studies, in particular of cancer heterogeneity, neurodegenerative diseases and cellular microenvironments within FFPE tissues, including archival clinical samples.
    DOI:  https://doi.org/10.1038/s41596-025-01256-3
  11. J Chromatogr B Analyt Technol Biomed Life Sci. 2025 Oct 04. pii: S1570-0232(25)00363-0. [Epub ahead of print]1267 124809
      Triple quadrupole (QQQ) MS based pseudotargeted lipidomics combines high coverage and quantitative accuracy, is commonly established by selecting the most responsive lipid ion pairs identified from high-resolution mass spectrometry (HRMS), then sending them to QQQ MS for quantification by multiple reaction monitoring. Due to the low resolution of QQQ MS, it may result in faulty peak identification in integration and method transition from HRMS to QQQ MS, thus, directly establish pseudotargeted lipidomics on HRMS is needed to improve the accuracy of present methods. We propose a method for rapidly screening high-resolution ion pairs for constructing multiplex-HRMS-based pseudotargeted lipidomics (MHPL). Firstly, high-resolution precursor and product ions for lipid quantification were obtained by HRMS. To solve the problem of lower acquisition speed in HRMS, we used the multiplex mode to simultaneously fragment co-eluting lipid precursor ions within one isolation window, scan the MS/MS mass spectra, and quantify the unique product ions (UPI) of co-eluting lipid (defined as Quan-PIs). Meanwhile, we provide a group of scripts for searching for lipid Quan-PIs in multiplex mode. The proposed MHPL strategy could ensure accurate quantification of 460 lipids within 5 injections, and was applied in serum differential lipid discovery for chronic obstructive pulmonary disease (COPD) patients. As a result, 47 differential lipids were found to comprise a potential biomarker panel for COPD diagnosis. The lipid identification and quantification in this work were conducted in the same instrument, and faulty peak identification was considerably reduced in integration and when transitioning methods from HRMS to QQQ MS.
    Keywords:  Chronic obstructive pulmonary disease; High-resolution mass spectrometry; Lipidomics; Multiplex; Pseudotargeted lipidomics
    DOI:  https://doi.org/10.1016/j.jchromb.2025.124809
  12. J Proteome Res. 2025 Oct 08.
      Comparative proteomics experiments reveal biomarkers by using statistical tests to determine proteins expressed with a higher abundance in one sample versus another. However, comparative experiments can be complicated by variability in all aspects of proteomics workflows. To account for variability, software for database searching contains retention-time alignment and imputation algorithms to correct for retention-time shifts and assign abundances to missing proteins. While these algorithms improve quantification and reduce processing time, we hypothesize that they alter statistical comparisons between samples when samples are searched together. Herein, we search the data for different cleanup methods or single proteins either separately or together in Progenesis Qi for proteomics database searching software. Our results show that searching samples together increases the number of identifications in each sample, enhances the protein similarity between samples, and leads to false transfers. Furthermore, we demonstrate that searching samples together affects protein abundance, differentially expressed proteins, and confidence scores due to retention-time alignment and imputation algorithms. Ultimately, we highlight that careful consideration of the search design is necessary to determine biomarkers in comparative proteomics experiments. Search results from the reanalyzed data set comparing sample-cleanup methods (MSV000094130) and single-protein data have been deposited into MassIVE (MSV000096112) and ProteomeXchange (PXD056868).
    Keywords:  database searching; imputation; missing proteins; proteomics; retention-time alignment; stochasticity
    DOI:  https://doi.org/10.1021/acs.jproteome.5c00429
  13. Anal Bioanal Chem. 2025 Oct 08.
      The separation and characterization of phosphorothioate (PS) diastereomers in GalNAc-conjugated siRNA presents a significant analytical challenge due to the high number of isomers present. To tackle this challenge, we explore and optimize various separation techniques, including chromatographic methods (ion-pair reversed-phase, anion exchange, and hydrophilic interaction liquid chromatography) and ion mobility mass spectrometry (IMS) to assess their efficacy in diastereomer separation. Our results indicate that AEX provides the highest diastereomer selectivity among the chromatographic techniques, although none achieved complete diastereomer separation for the chosen antisense and sense strand reference compounds. IMS, applied within a fragment-based tandem mass spectrometry approach, allows separation of all diastereomers of the antisense strand and partial resolution of the sense strand in the gas phase. The comparison of relative LC-UV quantification with IMS data reveals a strong correlation and suggests that IMS can effectively characterize diastereomer ratios not only qualitatively but also quantitatively, establishing IMS as a promising complementary analytical technique for diastereomer separation besides more established LC-UV methods.
    Keywords:  Diastereomers; GalNAc-conjugated siRNA; Ion mobility-mass spectrometry; Liquid chromatography; Phosphorothioate; Therapeutic oligonucleotides
    DOI:  https://doi.org/10.1007/s00216-025-06123-4
  14. Environ Sci Technol. 2025 Oct 09.
      Reliable quantification of polychlorinated alkanes (PCAs) remains a major challenge, hindering environmental research across diverse matrices. Each sample can contain over 500 homologue groups, collectively producing >1000 m/z ratios that require interference checks. High-resolution mass spectrometry methods vary in ionization signals and data formats and require specialized algorithms for quantification. CPxplorer streamlines data processing through the integration of three modules: (1) CPions generates target ion sets and isotopic thresholds for compound identification into the next module; (2) Skyline performs instrument-independent data integration, interference evaluation, and homologue profiling; and (3) CPquant deconvolves homologues and reports concentrations using reference standards and homologue profiles from Skyline. Evaluation of the workflow with NIST-SRM-2585 dust and ERM-CE100 fish tissue material yielded comparable results across raw data formats from different instruments. Further applications of CPxplorer across diverse matrices, including indoor dust, organic films, silicone wrist bands, and food samples, demonstrated the usefulness in biological and environmental monitoring. Compared to existing tools limited to qualitative detection, CPxplorer enables quantitative outputs, reduces processing time, and expands functionality to PCA-like substances (e.g., BCAs) and PCA degradation products (e.g., OH-PCAs). CPxplorer reduces learning barriers, empowers users to quantify PCAs across various analytical instruments, and contributes to generating comparable results in the field.
    Keywords:  analytical method; chlorinated paraffins; data harmonization; persistent organic pollutants; polychlorinated alkanes; quantification
    DOI:  https://doi.org/10.1021/acs.est.5c04928
  15. Anal Chem. 2025 Oct 06.
      Parathyroid hormone (PTH), an 84-amino acid polypeptide critical for calcium/phosphorus homeostasis, exhibits significant analytical challenges in clinical quantification, particularly in chronic kidney disease (CKD) patients due to its low circulating concentrations, biological matrix complexity, and interference from circulating PTH fragments. Traditional immunoassays may either overestimate the PTH level due to cross-reactivity with the PTH 7-84 or fail to quantify the antagonistic fragment. Highly sensitive and selective mass spectrometry (MS)-based methods could be used as the reference measurement procedure (RMP) for PTH assays, once the limitations of quantification thresholds and antibody-dependent workflows are addressed. Here, we introduce the first inline weak cation-exchange microsolid-phase extraction-tandem mass spectrometry (WCX-μSPE-MS/MS) method for simultaneous quantification of PTH 1-84 and its antagonist PTH 7-84 in clinical serum samples. A carboxyl-functionalized polystyrene nanosphere-modified capillary μSPE column with dual weak cation exchange (WCX) and nonpolar retention mechanisms is integrated with electrospray ionization-MS/MS, enabling online purification, enrichment, and detection in a single analysis. The nanoliter-scale capillary extraction can minimize matrix effects and improve sensitivity while greatly eliminating offline sample transfer steps. A limit of detection (LOD) as low as 6.0 pg/mL (PTH 1-84) or 9.0 pg/mL (PTH 7-84) is achieved, with relative standard deviations less than 10%. Our antibody-free strategy greatly reduces solvent/sample consumption, avoids manual errors, and has been successfully applied for accurate quantification of both PTH 1-84 and PTH 7-84 in clinical serum, demonstrating great potential to serve as an RMP for PTH assays, enhancing diagnostic accuracy for hyperparathyroidism, CKD, and renal bone diseases.
    DOI:  https://doi.org/10.1021/acs.analchem.5c03332
  16. STAR Protoc. 2025 Oct 08. pii: S2666-1667(25)00543-X. [Epub ahead of print]6(4): 104137
      Cysteine post-translational modifications are important for protein functions and protein-protein interactions. Here, we present a protocol to detect the reversibly oxidized and reduced cysteine residues of proteins using differential alkylation labeling techniques with liquid chromatography-mass spectrometry (LC-MS) analysis. We describe steps for tissue sample preparation, differential alkylation, trypsin digestion, and LC-MS analysis. We then detail procedures for protein identification and data analysis. This protocol has potential application in pinpointing the modified cysteine residues in organs and cells in various disease models. For complete details on the use and execution of this protocol, please refer to Oo et al.1.
    Keywords:  Health Sciences; Proteomics; Sequence analysis
    DOI:  https://doi.org/10.1016/j.xpro.2025.104137
  17. Immunology. 2025 Oct 08.
      Metabolic reprogramming is a hallmark of cancer, enabling tumour cells to flexibly adapt to fluctuating microenvironmental conditions, sustain uncontrolled proliferation, and acquire resistance to conventional therapies. Tumour metabolism is not limited to the classical Warburg effect but encompasses a dynamic interplay between glycolysis, oxidative phosphorylation (OXPHOS), fatty acid metabolism, and amino acid utilisation, each fine-tuned according to tissue context, tumour type, and stage of progression. Central regulators such as hypoxia-inducible factor-1 (HIF-1), MYC, p53, peroxisome proliferator-activated receptors (PPARs), oestrogen receptor (ER), and sterol regulatory element-binding proteins (SREBPs) orchestrate these pathways, linking nutrient availability to oncogenic signalling and transcriptional control. This review synthesises current evidence on these interconnected metabolic circuits and critically evaluates existing controversies, such as the dual reliance on glycolysis and OXPHOS, metabolic plasticity under therapeutic pressure, and the role of stromal-tumor metabolic crosstalk. Beyond established pathways, emerging areas are transforming our understanding of tumour metabolism. Single-cell metabolic profiling and spatial metabolomics reveal profound intratumoral heterogeneity, while immunometabolism highlights the bidirectional influence of cancer cells and immune cells within the tumour microenvironment (TME). Epigenetic regulation, driven by metabolites that serve as cofactors for chromatin-modifying enzymes, further integrates metabolic states with transcriptional reprogramming and therapy response. Translationally, targeting metabolic dependencies remains challenging; promising therapeutic opportunities are being developed, including inhibitors of lactate transporters, fatty acid oxidation, and glutamine metabolism. This review integrates mechanistic insights with translational perspectives, providing conceptual models, summary tables, and schematic illustrations to clarify complex networks and highlight clinically relevant opportunities. By mapping the evolving landscape of cancer metabolism, we aim to illuminate both the challenges and the therapeutic potential of exploiting metabolic vulnerabilities in oncology.
    Keywords:  OXPHOS; glycolysis; mediators; metabolic reprogramming; tumour microenvironment
    DOI:  https://doi.org/10.1111/imm.70045
  18. J Chromatogr A. 2025 Sep 22. pii: S0021-9673(25)00747-2. [Epub ahead of print]1763 466403
      Compound-Specific Isotope Analysis (CSIA) of amino acids (AAs) is increasingly applied in food authentication and environmental studies, where precise and accurate δ13C measurements are essential. This study systematically compares the performance of Gas Chromatography-Combustion-Isotope Ratio Mass Spectrometry (GC-C-IRMS) and Liquid Chromatography coupled to Isotope Ratio Mass Spectrometry (LC-co-IRMS) for δ13C analysis of essential and non-essential AAs. The GC-C-IRMS showed high analytical precision, with standard deviations typically below 0.5 ‰ for standard AAs and 0.8 ‰ for rice samples, in close agreement with EA-IRMS reference values. The LC-co-IRMS, while generally reliable, exhibited higher variability, with deviations up to 1.6 ‰ for standard AAs and 1.9 ‰ for samples. The GC-C-IRMS also provided better chromatographic resolution, shorter run times, and broader amino acid coverage but involved complex workflows, including derivatization and the use of hazardous reagents. In contrast, LC-co-IRMS offered a simpler, safer protocol with fewer correction steps, though with longer analysis times, reduced throughput, and higher water consumption. Despite these trade-offs, both methods yielded comparable δ13C values overall, with some differences for specific AAs. This study finds GC-C-IRMS as suitable for high-precision, high-throughput applications, while LC-co-IRMS is more appropriate for simplified, sustainable workflows, with method selection depending on research purposes and operational priorities.
    Keywords:  Amino acids; Carbon isotopic ratio; Compound specific analysis; GC-C-IRMS; LC-co-IRMS; Rice
    DOI:  https://doi.org/10.1016/j.chroma.2025.466403
  19. Biochem Pharmacol. 2025 Oct 07. pii: S0006-2952(25)00630-6. [Epub ahead of print] 117365
      Cancer cells exhibit significant metabolic reprogramming to support their rapid proliferation and survival. Most of the normal and cancer cells are glucose avid, which is metabolized, producing lactate (the Warburg effect). The urea cycle (UC) is traditionally associated with nitrogen detoxification in the liver. UC is boosted in normally proliferating cells; however, disruptions in UC activity are frequently observed in various cancers, leading to altered nitrogen metabolism and the accumulation of ammonia. This review covers the intricate relationship between the UC and cancer progression. We discuss how UC dysregulation contributes to tumorigenesis by promoting pyrimidine synthesis, altering amino acid metabolism, and modulating the tumor microenvironment. Additionally, we explore the impact of ammonia accumulation on cancer cell proliferation, stemness, and immune evasion. Understanding the metabolic rewiring of the UC in cancer offers novel therapeutic opportunities. Targeting UC enzymes or ammonia detoxification pathways may provide effective strategies to inhibit tumor growth and enhance the efficacy of immunotherapeutics.
    Keywords:  Ammonia; Cancer; Metabolism; Tumor microenvironment; Urea cycle
    DOI:  https://doi.org/10.1016/j.bcp.2025.117365
  20. Oncogene. 2025 Oct 04.
      Lipid metabolism is among the most frequently dysregulated metabolic processes in human cancer, yet how cellular lipids, the end products of lipogenesis, and their composition are altered to support various aspects of cancer remains poorly understood. Here, we show that targeting SREBP-dependent lipogenesis via FGH10019, an orally available SREBP inhibitor, enhances docetaxel-induced cytotoxicity in human prostate cancer cells in vitro and in vivo. Mechanistically, suppression of lipid biosynthesis leads to a shift in cellular lipid composition toward polyunsaturated lipids, resulting in increased membrane permeability and intracellular docetaxel accumulation. Thus, our findings reveal a critical role of de novo lipogenesis in protecting cancer cells from chemotherapeutics and suggest that treatment with lipogenesis inhibitors could improve the efficacy of chemotherapy against human prostate cancer.
    DOI:  https://doi.org/10.1038/s41388-025-03588-6
  21. Anal Chim Acta. 2025 Nov 22. pii: S0003-2670(25)01002-5. [Epub ahead of print]1376 344608
       BACKGROUND: Single-cell mass spectrometry (SCMS) deepens the insight into current bioanalytical science. Precise cell positioning is a critical step in SCMS workflow because it provides accurate spatial coordinates of the target cell for downstream analysis. However, conventional approaches rely on manual cell localization, resulting in compromised analysing throughput. Microfluidic techniques exhibit inherent advantages in rare cell isolation, whereas the encapsulation nature of the microfluidic chip confines the cells in a sealed chamber, making it incompatible with subsequent cellular extraction and mass spectrometry.
    RESULTS: In this study, we developed a reversibly-bonded microfluidic chip that achieves seamless integration with SCMS workflow. Our method features a flexible bonding strategy where the chip maintains bonding stability during cell isolating stage, followed by controlled disassembly to expose the entrapped cells into ambient environment for on-chip SCMS analysis. The results show that single-cells are patterned in geometrically defined positions within 4 min based on size-dependent trapping mechanics, enabling deterministic spatial addressing. In addition, the precisely-engineered cellular trap creates discrete microenvironments for single-cell sampling, and the compartmentalization of the extracting droplet prevents intercell cross-talk in SCMS procedure. The established platform demonstrates exceptional efficacy in single-cell metabolic analysis, as evidenced by the successful detection of 170 metabolites in bladder cancer cells and cellular subtyping is readily achieved based on metabolic fingerprints.
    SIGNIFICANCE: The integration of reversible microfluidics and SCMS bridges the gap between high-throughput cell manipulation and post-processing analysis, representing a novel way for single-cell metabolomics studies.
    Keywords:  Microfluidic chip; On-chip single-cell mass spectrometry; Reversible bonding; Single-cell positioning
    DOI:  https://doi.org/10.1016/j.aca.2025.344608
  22. Xenobiotica. 2025 Oct 11. 1-16
      Metabolomics offers a sensitive and comprehensive approach to detect early biochemical changes induced by environmental contaminants, providing insights beyond traditional toxicity assays. In this study, we have developed a targeted metabolomics workflow using low-resolution tandem mass spectrometry (MS/MS) to identify metabolic alterations in zebrafish (Danio rerio) embryos exposed to lowest concentrations (1 µg/L) and highest concentration of (1mg/L) of the antibiotic's amoxicillin and clarithromycin. A library-assisted MRM-EPI (Multiple Reaction Monitoring Enhanced Product Ion) approach was employed using a Q-TRAP LC-MS/MS system, enabling the detection and structural confirmation of 108 endogenous metabolites. Based on the confirmed metabolites using library search, developed a targeted MRM-EPI method optimized for sensitivity, reproducibility, and specificity. Multivariate statistical analyses (PCA and PLS-DA) showed notable metabolic changes in exposed embryos compared to controls, which included significant changes in amino acid, purine, lipid, and energy metabolism. These alterations imply that even sub-lethal antibiotic exposures may affect vital physiological functions, potentially affecting an organism's development and survival. Using zebrafish embryos as a model organism provided a practical, sensitive, and ethically suitable system for environmental toxicity evaluation. This study offers a reproducible MRM-driven metabolomics approach that contributes to developing predictive toxicology, which impacts ecological risk assessment and environmental monitoring.
    Keywords:  LC-MS/MS; MRM–EPI workflow; MS/MS library; biomarkers exposure; environmental metabolomics
    DOI:  https://doi.org/10.1080/00498254.2025.2571653
  23. Cancer Med. 2025 Oct;14(19): e71291
       BACKGROUND: RT4 bladder cancer cell line, derived from a nonmuscle-invasive low-grade subtype, is one of the few neoplastic cell lineages that maintain high expression of the candidate tumor suppressor ALDH1L1. Here, we investigated how differential ALDH1L1 expression affects cellular characteristics and tumorigenicity of RT4 cells as well as tumor metabotypes.
    METHODS: We characterized RT4 cells and two shRNA clones (sh506/low ALDH1L1 expression; sh572/ALDH1L1 is lost) for proliferation, migration, clonogenic capacity, and mitochondrial respiration. We have further evaluated the tumorigenic potential of RT4 cells and the two clones in nude mice and compared metabotypes of derived tumors using untargeted metabolomics.
    RESULTS: Both clones with diminished ALDH1L1 expression exhibited increased proliferation rates with doubling times of 19.4 h (sh506) and 23.2 h (sh572) versus 36.3 h for RT4 cells. Downregulation of ALDH1L1 expression also enhanced motility and clonogenic capacity. Proliferation and clonogenic capacity were highest for the sh506 clone (low ALDH1L1 expression), while motility was strongest for the sh572 clone (complete ALDH1L1 loss). Both clones showed altered energy metabolism, as indicated by a reduced basal oxygen consumption rate and enhanced maximal respiration rate following oligomycin treatment. Mouse xenograft tumors derived from ALDH1L1-deficient RT4 clones were significantly larger than RT4 cell-derived tumors. Of note, complete ALDH1L1 loss (sh572 clone) was less advantageous for tumor growth than the partial loss of the protein (sh506 clone). Untargeted metabolomics has shown that tumors with downregulated ALDH1L1 have altered the metabolism of fatty acids, amino acids, CoA, and acylcarnitines. Alterations in several key pathways, including glutathione metabolism (sh506), and TCA cycle (sh572), depend on the extent of ALDH1L1 downregulation.
    CONCLUSIONS: Our study underscores ALDH1L1 as a key metabolic regulator of proliferation, migration, and tumorigenicity in RT4 bladder cancer cells, suggesting that retaining low ALDH1L1 expression can provide a metabolic advantage for growth of aggressive tumors.
    Keywords:   ALDH1L1 ; RT4 bladder cancer cells; one‐carbon metabolism; untargeted metabolomics; xenograft tumors
    DOI:  https://doi.org/10.1002/cam4.71291
  24. Microbiol Spectr. 2025 Oct 10. e0191225
      An essential aspect of population-based research is collecting samples outside of a clinical setting. This is crucial because microbial populations are highly dynamic, varying significantly across hosts, environments, and time points, a variability that clinical sample collection alone cannot fully capture. At-home sample collection enables the inclusion of a larger and more diverse group of participants, accounting for differences in ethnicity, age, and other factors. However, managing large studies is challenging due to the complexities involved in sample acquisition, processing, and analysis. Building on our previous work demonstrating the effectiveness of single 1 mL barcoded, racked Matrix Tubes in reducing sample processing time and well-to-well contamination for paired DNA and metabolite extraction, we further validate this method against a previously benchmarked plate-based approach using the same extraction reagents. This validation focuses on samples from the built environment, human skin, human saliva, and feces from mice and humans. Importantly, we explore the impact of using a mix of bead sizes during bead-beating for cell lysis, demonstrating that it enhances taxonomic recovery compared to a single bead size. Finally, we assess the potential of 95% isopropanol for room-temperature sample preservation. Our results show that isopropanol performs comparably to 95% ethanol in many cases, suggesting it is viable as an alternative when ethanol is unavailable. Beyond minimizing contamination, halving processing time, eliminating human error during sample plating, and streamlining metadata curation, the Matrix tube approach produces metabolomic, 16S, and shotgun metagenomic data consistent with the Plate-based Method for both high- and low-biomass samples.
    IMPORTANCE: Numerous studies have linked the microbiome to human and environmental health, yet many fundamental questions remain unanswered. Large-scale studies with robust statistical power are required to identify important covariates against a background of confounding factors. Cross-contamination, limited throughput, and human error have been identified as major setbacks when processing large numbers of samples. We present a streamlined method for sample accession and extraction of metabolites and DNA for both high- and low-biomass samples. This approach, previously shown to significantly reduce cross-contamination, employs an automation-friendly, single barcoded tube per sample. Additionally, we demonstrate that 95% isopropanol serves as an effective ambient-temperature storage solution for many sample types, providing an alternative in regions where ethanol is unavailable or restricted. This method has significant implications for the field, enabling large-scale studies to generate accurate insights with greater efficiency and expanded accessibility in situations in which ethanol is more costly or otherwise not available.
    Keywords:  16S rRNA gene; automation; contamination; large-scale studies; metabolomics; metagenomics; microbiome; sample storage; study design
    DOI:  https://doi.org/10.1128/spectrum.01912-25
  25. Proteomics. 2025 Oct 07. e70052
      Chromatographic column selection can impact proteomic profiling, yet comparative studies remain limited. Here, we evaluate the performance of a conventional flame-pulled Accucore packed-bed capillary column and a microfabricated pillar array column (µPAC) in a sample multiplexed global proteome profiling experiment using six human cell lines prepared in triplicate as a TMTpro18-plex. Overall, both chromatography columns exhibited comparable performance. Specifically, the number and overlap of quantified peptides, as well as proteins, was similar between columns. Principal component and hierarchical clustering analyses highlighted reproducible cell line-driven patterns, while correlation analyses showed high replicate consistency across column formats. Similarly, analytical parameters like XCorr scores, signal-to-noise ratio, and peak resolution showed consistency. These findings demonstrate the potential for using robust, standardized microfluidic columns, such as µPAC, in lieu of traditional pull-tipped capillary columns without sacrificing depth or quantitative accuracy. Key advantages of µPAC include its ease of use and durability in a uniform format, although this advantage does come at a higher cost. This comparative analysis offers valuable insights into column selection for TMT-based quantitative proteomics. SUMMARY: We compare a conventional flame-pulled Accucore resin-packed capillary column and a microfabricated pillar array column (µPAC)-in the context of a TMTpro18-plex experiment using six diverse human cell lines. We evaluate peptide and protein quantification, analytical performance, and reproducibility of both column formats. We demonstrate comparable performance between the two columns and highlight the potential of the robust and standardized µPAC as a viable alternative to traditional capillary columns. These findings offer insights for optimizing column selection in isobaric tag-based proteomic workflows, balancing depth, precision, ease of use, and cost. We provide researchers with evidence-based guidance to enhance experimental design and advance proteomic profiling.
    Keywords:  Accucore; Ascend; TMT; chromatography; µPAC
    DOI:  https://doi.org/10.1002/pmic.70052
  26. Anal Chem. 2025 Oct 10.
      Spectral library searching is a key method for compound annotation in mass spectrometry; however, existing libraries often suffer from high data heterogeneity, varying spectral quality, or limited accessibility. These issues are particularly significant in food safety, where the lack of comprehensive reference data hampers the identification of hazardous compounds. To address these limitations, we developed the WFSR Food Safety Mass Spectral Library, a freely accessible tandem mass spectral library focused on food contaminants, residues, and hazardous compounds. This library contains 6993 manually curated spectra from 1001 compounds acquired in positive ionization mode using ultrahigh-performance liquid chromatography coupled to an Orbitrap IQ-X Tribrid mass spectrometer. Spectra were recorded at seven collision energies under standardized conditions. Comprehensive metadata are provided, including common names, CAS, SMILES, InChIKeys, retention times, and compound classes. The library is publicly available via a dedicated website (https://www.wur.nl/en/show/food-safety-mass-spectral-library.htm) and through the GNPS repository, adhering to FAIR data principles to facilitate community reuse. Comparisons with major repositories (GNPS, MassBank, MoNA, and MSnLib) showed that 216 compounds (22.2%) are unique to our library. Further analysis using molecular networking and MS2Query revealed that about 38% of the compounds lack reliable matches in public libraries. The WFSR spectral library is designed to improve the annotation of food toxicants and facilitate the identification of structural analogues using computational tools. This library is part of an ongoing initiative with future updates planned to include negative ionization mode spectra and an expanded compound repertoire, aiming to advance food safety monitoring.
    DOI:  https://doi.org/10.1021/acs.analchem.5c03020
  27. J Pharm Biomed Anal. 2025 Oct 03. pii: S0731-7085(25)00519-9. [Epub ahead of print]268 117178
      The folate cycle is essential for regulating metabolic processes. Simultaneous measurement of folate cycle intermediates is crucial for understanding metabolic disruptions in hematopoietic, nervous, renal and cardiovascular diseases. Currently, liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for folate cycle metabolites showed poor retention for highly polar compounds in reversed-phase separations with long analytical run time (30 min). Herein, we developed a novel LC-MS/MS method using hydrophilic interaction liquid chromatography (HILIC) mode for simultaneous measurement of 10 key folate cycle metabolites in human plasma, including 5 folate intermediates, 4 related amino acids, and a cofactor (VB12), with enhanced chromatographic retention and reduced analysis time (8.5 min) without derivatization. Through further method validation, all analytes demonstrated acceptable linearity (R² > 0.989), precision (intra-day precision: 1.3-11.3 %; inter-day precision: 3.4-14.6 %), recovery (89.5-113.8 %) and reasonable matrix effect (81.6-115.8 %). The results presented that all intermediates were stable for 5 h at 5°C (autosampler), 12 h at -40°C and 24 h at -80°C. Moreover, the method was successfully applied in clinical plasma from critically ill patients, revealing distinct metabolic perturbations in acute kidney injury (AKI) inpatients compared with non-AKI controls (NAKI). Levels of 5-MTHF and Gly were significantly elevated in the AKI group. Correlation analysis revealed that SCr levels were positively correlated with both 5-MTHF (r = 0.26, p = 0.04) and hCys (r = 0.27, p = 0.04) concentrations. The study is promising to evaluate folate nutritional status to mitigate the risks of folate-related diseases, such as megaloblastic anemia and neural tube defects.
    Keywords:  Folate cycle; HILIC; LC-MS/MS; Plasma
    DOI:  https://doi.org/10.1016/j.jpba.2025.117178